China Antidiabetic Biguanides Sales Market Report 2021

August 2016 | 104 pages | ID: C5E73BC70DDEN
QYResearch

Abstracts

This report studies sales (consumption) of Antidiabetic Biguanides in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Sanofi
• Takeda Pharmaceuticals
• Eli Lilly
• Merck & Co.
• Novo Nordisk
• Bristol-Myers Squibb
• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Boehringer Ingelheim

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Antidiabetic Biguanides in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

China Antidiabetic Biguanides Sales Market Report 2021

1 ANTIDIABETIC BIGUANIDES OVERVIEW

1.1 Product Overview and Scope of Antidiabetic Biguanides
1.2 Classification of Antidiabetic Biguanides
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of Antidiabetic Biguanides
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 China Market Size (Value and Volume) of Antidiabetic Biguanides (2011-2021)
  1.4.1 China Antidiabetic Biguanides Sales, Revenue and Price (2011-2021)
  1.4.2 China Antidiabetic Biguanides Sales and Growth Rate (2011-2021)
  1.4.3 China Antidiabetic Biguanides Revenue and Growth Rate (2011-2021)

2 CHINA ANTIDIABETIC BIGUANIDES COMPETITION BY MANUFACTURERS

2.1 China Antidiabetic Biguanides Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 China Antidiabetic Biguanides Revenue and Share by Manufactures (2015 and 2016)

3 CHINA ANTIDIABETIC BIGUANIDES (VOLUME AND VALUE) BY TYPE

3.1 China Antidiabetic Biguanides Sales and Market Share by Type (2011-2021)
3.2 China Antidiabetic Biguanides Revenue and Market Share by Type (2011-2021)

4 CHINA ANTIDIABETIC BIGUANIDES (VOLUME) BY APPLICATION

5 CHINA ANTIDIABETIC BIGUANIDES MANUFACTURERS ANALYSIS

5.1 Sanofi
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Antidiabetic Biguanides Product Type and Technology
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Antidiabetic Biguanides Sales, Revenue, Price of Sanofi (2015 and 2016)
5.2 Takeda Pharmaceuticals
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Medicine Product Type and Technology
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Medicine Sales, Revenue, Price of Takeda Pharmaceuticals (2015 and 2016)
5.3 Eli Lilly
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Eli Lilly Product Type and Technology
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Eli Lilly Sales, Revenue, Price of Eli Lilly (2015 and 2016)
5.4 Merck & Co.
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 GlaxoSmithKline Product Type and Technology
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Merck & Co. Sales, Revenue, Price of Merck & Co. (2015 and 2016)
5.5 Novo Nordisk
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 Novo Nordisk Product Type and Technology
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Novo Nordisk Sales, Revenue, Price of Novo Nordisk (2015 and 2016)
5.6 Bristol-Myers Squibb
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 Bristol-Myers Squibb Product Type and Technology
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Bristol-Myers Squibb Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
5.7 Pfizer
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 Pfizer Product Type and Technology
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)
5.8 AstraZeneca
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 AstraZeneca Product Type and Technology
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 AstraZeneca Sales, Revenue, Price of AstraZeneca (2015 and 2016)
5.9 GlaxoSmithKline
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 GlaxoSmithKline Product Type and Technology
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 GlaxoSmithKline Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
5.10 Boehringer Ingelheim
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 Boehringer Ingelheim Product Type and Technology
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Boehringer Ingelheim Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)

6 ANTIDIABETIC BIGUANIDES TECHNOLOGY AND DEVELOPMENT TREND

6.1 Antidiabetic Biguanides Technology Analysis
6.2 Antidiabetic Biguanides Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetic Biguanides
Table Classification of Antidiabetic Biguanides
Figure China Sales Market Share of Antidiabetic Biguanides by Type in 2015
Table Applications of Antidiabetic Biguanides
Figure China Sales Market Share of Antidiabetic Biguanides by Application in 2015
Table China Antidiabetic Biguanides Sales, Revenue and Price (2011-2021)
Figure China Antidiabetic Biguanides Sales and Growth Rate (2011-2021)
Figure China Antidiabetic Biguanides Revenue and Growth Rate (2011-2021)
Table China Antidiabetic Biguanides Sales of Key Manufacturers (2015 and 2016)
Table China Antidiabetic Biguanides Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antidiabetic Biguanides Sales Share by Manufacturers
Figure 2016 Antidiabetic Biguanides Sales Share by Manufacturers
Table China Antidiabetic Biguanides Revenue by Manufacturers (2015 and 2016)
Table China Antidiabetic Biguanides Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Antidiabetic Biguanides Revenue Share by Manufacturers
Table 2016 China Antidiabetic Biguanides Revenue Share by Manufacturers
Table China Antidiabetic Biguanides Sales and Market Share by Type (2011-2021)
Table China Antidiabetic Biguanides Sales Share by Type (2011-2021)
Figure Sales Market Share of Antidiabetic Biguanides by Type (2011-2021)
Figure China Antidiabetic Biguanides Sales Growth Rate by Type (2011-2021)
Table China Antidiabetic Biguanides Revenue and Market Share by Type (2011-2021)
Table China Antidiabetic Biguanides Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Antidiabetic Biguanides by Type (2011-2021)
Figure China Antidiabetic Biguanides Revenue Growth Rate by Type (2011-2021)
Table China Antidiabetic Biguanides Sales and Market Share by Application (2011-2021)
Table China Antidiabetic Biguanides Sales Share by Application (2011-2021)
Figure Sales Market Share of Antidiabetic Biguanides by Application (2011-2021)
Figure China Antidiabetic Biguanides Sales Growth Rate by Application (2011-2021)
Table Sanofi Basic Information List
Table Antidiabetic Biguanides Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Takeda Pharmaceuticals Basic Information List
Table Antidiabetic Biguanides Sales, Revenue, Price of Takeda Pharmaceuticals (2015 and 2016)
Table Eli Lilly Basic Information List
Table Antidiabetic Biguanides Sales, Revenue, Price of Eli Lilly (2015 and 2016)
Table Merck & Co. Basic Information List
Table Antidiabetic Biguanides Sales, Revenue, Price of Merck & Co. (2015 and 2016)
Table Novo Nordisk Basic Information List
Table Antidiabetic Biguanides Sales, Revenue, Price of Novo Nordisk (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Antidiabetic Biguanides Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table Pfizer Basic Information List
Table Antidiabetic Biguanides Sales, Revenue, Price of Pfizer (2015 and 2016)
Table AstraZeneca Basic Information List
Table Antidiabetic Biguanides Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Antidiabetic Biguanides Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Boehringer Ingelheim Basic Information List
Table Antidiabetic Biguanides Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)